A novel PET perfusion radiotracer, 18F-flurpiridaz, can diagnose coronary artery disease (CAD) in obese patients with a higher sensitivity and specificity compared to 99Tc-SPECT myocardial perfusion imaging (MPI)
News | SNMMI
Novel Radiotracer Demonstrates High Diagnostic Efficacy for Obese Patients with Coronary Artery Disease

June 28, 2023 โ€” A novel PET perfusion radiotracer, 18F-flurpiridaz, can diagnose coronary artery disease (CAD) in obese ...

Home June 28, 2023
Home
Feature | ASE | Christine Book
ASE Presents Rebecca Hahn, MD, FASE, with 2023 Physician Lifetime Achievement Award, Recognizes Other Award Recipients

June 27, 2023 โ€” The 2023 American Society of Echocardiography Scientific Sessions, ASE 2023, โ€œFoundations and the future ...

Home June 27, 2023
Home
News | Computed Tomography (CT)
SCCT Issues New Expert Consensus, Provides Multi-society Update to Cardiac CT Medical Terminology

June 27, 2023 โ€” The Society of Cardiovascular Computed Tomography (SCCT) has released an expert consensus document ...

Home June 27, 2023
Home
Preventing contrast induced nephropathy and managing patients with chronic kidney disease remain major challenges in the cardiac catheterization lab. In recent years, contrast supply shortages have presented a new challenge to care delivery.
Sponsored Content | Webinar | Intra-Vascular Ultrasound (IVUS)
WEBINAR NOW AVAILABLE ON DEMAND: Improving Patient Outcomes and Reducing Contrast Utilization in the Cath Lab

Preventing contrast induced nephropathy and managing patients with chronic kidney disease remain major challenges in the ...

Home June 27, 2023
Home
Jubilant DraxImage Inc., dba Jubilant Radiopharma, a wholly-owned subsidiary of Jubilant Pharma Limited, announced the clearance by the FDA to use its RUBY Rubidium Elution System and RUBY-FILL (Rubidium Rb82 generator) in mobile settings.
News | Cardiac Imaging
Jubilant Radiopharma Introduces RUBY Mobile Solutions

June 26, 2023 โ€” Jubilant DraxImage Inc., dba Jubilant Radiopharma, a wholly-owned subsidiary of Jubilant Pharma Limited ...

Home June 26, 2023
Home
Day-long summit organized by CRF and Fogarty Innovation will convene clinicians, entrepreneurs, industry, and government stakeholders for education, collaboration, and real-world insight
News | TCT
MedTech Innovation Forum Leads Day One at TCT 2023

June 26, 2023 โ€” Building on the resounding success of last yearโ€™s standing-room-only debut, the Cardiovascular Research ...

Home June 26, 2023
Home
Day-long summit organized by CRF and Fogarty Innovation will convene clinicians, entrepreneurs, industry, and government stakeholders for education, collaboration, and real-world insight
News | Stents Carotid
InspireMD Announces Completion of Enrollment in C-Guardians U.S. Investigational Device Exemption (IDE) Clinical Trial

June 26, 2023 โ€” InspireMD, Inc., developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of ...

Home June 26, 2023
Home
Teleflexย and Arrow International recall ARROW endurance extended dwell peripheral catheter system due to risk of catheter separation and leakage
News | Catheter
Teleflex and Arrow International Recall ARROW Endurance Extended Dwell Peripheral Catheter System

June 26, 2023 โ€” The U.S. Food and Drug Administration (FDA) has issued a Class I recall on the Teleflex and Arrow ...

Home June 26, 2023
Home
Latest iteration of Philips Compact Ultrasound System expands access to high-quality cardiac imaging at the patient bedside and beyond
News | ASE
Philips Helps Deliver Diagnostic Confidence in Echocardiography with Ultrasound Compact 5500CV at ASE 2023

June 23, 2023 โ€” Building on its established leadership in cardiovascular ultrasound, Philips will showcase its ...

Home June 23, 2023
Home
Randomized clinical trial enrolled patients with acute chest pain, mildly elevated troponin
News | Cardiovascular Clinical Studies
Less-invasive Cardiac MRI Is a Valuable Diagnostic Tool in the Early Evaluation of Patients with Acute Chest Pain

June 22, 2023 โ€” An estimated 3 million patients visit emergency departments each year with acute chest pain and mildly ...

Home June 22, 2023
Home
Technique had a median overall 1.5 Likert score with nearly 80% of segments rated good or excellent
News | Computed Tomography (CT)
Photon-counting CT Noninvasively Detects Heart Disease in High-risk Patients

June 22, 2023 โ€” New ultra-high-resolution CT technology enables excellent image quality and accurate diagnosis of ...

Home June 22, 2023
Home
Clinical trial establishes Lankenau as one of the most comprehensive heart valve centers nationally by offering yet another alternative to open-heart surgery
News | Structural Heart
Lankenau Medical Center Performs First Minimally Invasive Procedure for Aortic Regurgitation in Philadelphia Region

June 22, 2023 โ€” Lankenau Medical Center, part of Main Line Health, has performed the first minimally invasive catheter ...

Home June 22, 2023
Home
The Society of Interventional Radiology (SIR) published a new position statement offering recommendations on the management of chronic iliofemoral venous obstruction with endovascular placement of metallic stents.
News | Interventional Radiology
Newly Published Society of Interventional Radiology Position Statement Outlines Appropriate Use of Endovascular Management for Treatment of Chronic Iliofemoral Venous Occlusions

June 22, 2023 โ€” The Society of Interventional Radiology (SIR) published a new position statement offering ...

Home June 22, 2023
Home
The Midwest company will begin offering EchoSolv, an artificial intelligence clinical decision support platform designed to help detect severe aortic stenosis, to providers throughout the country.
News | Artificial Intelligence
Cassling Connects Cardiologists with Revolutionary AI Software

June 22, 2023 โ€” Cassling has announced a partnership with the goal of benefiting cardiovascular practices throughout the ...

Home June 22, 2023
Home
Developed in collaboration with Mayo Clinic, with support from Pfizer, this ECG-AI algorithm aims to aid physicians in earlier identification of cardiac amyloidosis
News | ECG
Anumana Receives U.S. FDA Breakthrough Device Designation for its Cardiac Amyloidosis Algorithm

June 21, 2023 โ€” Anumana, Inc., a leading AI-driven health technology company, has received Breakthrough Device ...

Home June 21, 2023
Home
ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now